DK1102745T3 - Fremgangsmåde til fremstilling af zofenoprilcalciumsalt - Google Patents

Fremgangsmåde til fremstilling af zofenoprilcalciumsalt

Info

Publication number
DK1102745T3
DK1102745T3 DK99939416T DK99939416T DK1102745T3 DK 1102745 T3 DK1102745 T3 DK 1102745T3 DK 99939416 T DK99939416 T DK 99939416T DK 99939416 T DK99939416 T DK 99939416T DK 1102745 T3 DK1102745 T3 DK 1102745T3
Authority
DK
Denmark
Prior art keywords
zofenopril
salt
calcium salt
preparation
potassium salt
Prior art date
Application number
DK99939416T
Other languages
English (en)
Inventor
Raffaello Giorgi
Antonio Giachetti
Carlo Mannucci
Anita Falezza
Original Assignee
Menarini Int Operations Lu Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Int Operations Lu Sa filed Critical Menarini Int Operations Lu Sa
Application granted granted Critical
Publication of DK1102745T3 publication Critical patent/DK1102745T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F11/00—Compounds of calcium, strontium, or barium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Geology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK99939416T 1998-08-04 1999-07-30 Fremgangsmåde til fremstilling af zofenoprilcalciumsalt DK1102745T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998MI001833A IT1301993B1 (it) 1998-08-04 1998-08-04 Processo per la preparazione di zofenopril sale di calcio.

Publications (1)

Publication Number Publication Date
DK1102745T3 true DK1102745T3 (da) 2004-08-02

Family

ID=11380611

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99939416T DK1102745T3 (da) 1998-08-04 1999-07-30 Fremgangsmåde til fremstilling af zofenoprilcalciumsalt

Country Status (32)

Country Link
US (2) US6521760B1 (da)
EP (1) EP1102745B1 (da)
JP (1) JP2002522417A (da)
KR (1) KR100593428B1 (da)
CN (1) CN1146538C (da)
AT (1) ATE266635T1 (da)
AU (1) AU5372299A (da)
BG (1) BG65022B1 (da)
BR (1) BR9912842A (da)
CA (1) CA2339283C (da)
CU (1) CU23171A3 (da)
CZ (1) CZ301908B6 (da)
DE (1) DE69917282T2 (da)
DK (1) DK1102745T3 (da)
EA (1) EA003454B1 (da)
EE (1) EE04798B1 (da)
ES (1) ES2221417T3 (da)
HK (1) HK1039616B (da)
HR (1) HRP20010083B1 (da)
HU (1) HU227557B1 (da)
IL (1) IL141222A0 (da)
IT (1) IT1301993B1 (da)
NO (1) NO319773B1 (da)
PL (1) PL193828B1 (da)
PT (1) PT1102745E (da)
RS (1) RS49768B (da)
SI (1) SI1102745T1 (da)
SK (1) SK285527B6 (da)
TR (1) TR200100272T2 (da)
UA (1) UA65628C2 (da)
WO (1) WO2000007984A1 (da)
ZA (1) ZA200100907B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1899297E (pt) * 2005-07-01 2016-03-21 Generics Uk Ltd Zofenopril de cálcio em forma polimórfica c
EA012845B1 (ru) * 2005-12-09 2009-12-30 Менарини Интернэшнл Оперейшнс Люксембург С. А. Фармацевтическая композиция, содержащая зофеноприл и hctz, для лечения гипертензии
RS53733B1 (sr) * 2006-05-26 2015-06-30 Generics Postupci za pripremu zofenopril kalcijuma
GB0715626D0 (en) * 2007-08-10 2007-09-19 Generics Uk Ltd Crystalline form of zofenopril calcium
CA2715726C (en) * 2008-02-27 2014-12-02 Vinayak Gore Novel crystalline forms
US8853421B2 (en) 2008-02-27 2014-10-07 Generics [Uk] Limited Crystalline forms of zofenopril calcium
WO2010084515A2 (en) * 2009-01-23 2010-07-29 Glenmark Generics Limited A process for the preparation of zofenopril and its pharmaceutically acceptable salts thereof
SI23949A (sl) 2011-12-19 2013-06-28 Silverstone Pharma Nove kristalne soli zofenoprila, postopek za njihovo dobivanje in njihova uporaba v terapiji
CN104138359B (zh) * 2013-05-06 2016-03-02 扬子江药业集团上海海尼药业有限公司 佐芬普利钙片的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105776A (en) * 1976-06-21 1978-08-08 E. R. Squibb & Sons, Inc. Proline derivatives and related compounds
US4154935A (en) * 1978-02-21 1979-05-15 E. R. Squibb & Sons, Inc. Halogen substituted mercaptoacylamino acids
US4316906A (en) * 1978-08-11 1982-02-23 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of substituted prolines

Also Published As

Publication number Publication date
HRP20010083B1 (en) 2005-02-28
YU7501A (sh) 2005-06-10
CU23171A3 (es) 2006-09-22
HUP0103826A3 (en) 2002-03-28
JP2002522417A (ja) 2002-07-23
ES2221417T3 (es) 2004-12-16
IT1301993B1 (it) 2000-07-20
ZA200100907B (en) 2001-10-04
HU227557B1 (en) 2011-08-29
NO20010552D0 (no) 2001-02-01
CA2339283C (en) 2009-03-17
CN1146538C (zh) 2004-04-21
PL193828B1 (pl) 2007-03-30
HK1039616A1 (en) 2002-05-03
NO20010552L (no) 2001-02-01
IL141222A0 (en) 2002-03-10
HRP20010083A2 (en) 2002-02-28
KR100593428B1 (ko) 2006-06-28
EP1102745B1 (en) 2004-05-12
HUP0103826A2 (hu) 2002-02-28
US6515012B2 (en) 2003-02-04
RS49768B (sr) 2008-06-05
HK1039616B (zh) 2004-10-08
SI1102745T1 (en) 2004-10-31
US6521760B1 (en) 2003-02-18
BR9912842A (pt) 2001-10-16
US20020156293A1 (en) 2002-10-24
SK1632001A3 (en) 2001-09-11
ITMI981833A1 (it) 2000-02-04
DE69917282T2 (de) 2005-05-25
PT1102745E (pt) 2004-08-31
UA65628C2 (uk) 2004-04-15
ITMI981833A0 (it) 1998-08-04
EA003454B1 (ru) 2003-06-26
CZ301908B6 (cs) 2010-07-28
NO319773B1 (no) 2005-09-12
BG105176A (en) 2001-11-30
EE200100065A (et) 2002-06-17
SK285527B6 (sk) 2007-03-01
CZ2001408A3 (cs) 2001-07-11
WO2000007984A1 (en) 2000-02-17
KR20010072171A (ko) 2001-07-31
EA200100095A1 (ru) 2001-08-27
DE69917282D1 (de) 2004-06-17
PL345814A1 (en) 2002-01-14
BG65022B1 (bg) 2006-12-29
CN1316992A (zh) 2001-10-10
AU5372299A (en) 2000-02-28
TR200100272T2 (tr) 2001-05-21
CA2339283A1 (en) 2000-02-17
EP1102745A1 (en) 2001-05-30
EE04798B1 (et) 2007-04-16
ATE266635T1 (de) 2004-05-15

Similar Documents

Publication Publication Date Title
BR0308385A (pt) Cristais de ácido (met) acrìlico e processo para produzir e purificar ácido (met) acrìlico aquoso
CA2473900A1 (en) A process for recovery of low sodium salt from bittern
NO20010552D0 (no) Fremgangsmåte for fremstilling av zofenopril kalsiumsalt
DK1113990T3 (da) Fremgangsmåde til fremstilling af miljøvenlige krystaller af natriumchlorid
GB2437006A (en) Salts assisted selective extraction of 6-acetyl-4.1',6'trichlorogalactosucrose and 4,1',6'trichlorogalactosucrose from aqueous reaction mixture
DK1115742T3 (da) Rensning af fibrinogen fra mælk ved anvendelse af kationbytningskromatografi
CA2425615A1 (en) Process for the purification of gabapentin using a strong cation exchange resin
MA29690B1 (fr) Procede de preparation de la 4beta-amino-4'-demethyl-4-desoxypodophyllotoxine
KR970001305A (ko) 발린 정제 방법
HRP20020887B1 (en) Method for synthesis of n-[(s)-1-carboxybutyl]-(s)-alanine esters and use in synthesis of perindopril
EA200501734A1 (ru) Способ получения (4-гидрокси-6-оксотетрагидропиран-2-ил)ацетонитрила и его производных
PL358986A1 (en) Method for producing 5-aminosalicyclic acid
HRP20000749B1 (hr) Pročišćavanje karboksaldehida
DK1419107T3 (da) Samretarderende midler til fremstilling af renset saltvand
DK1284978T3 (da) Fremgangsmåde til oprensning af et salt af clavulansyre
SE9903345D0 (sv) Novel process
DE50109873D1 (de) Verfahren zur herstellung von 1-methyl-3-nitroguanidin
EA200200783A2 (ru) Почвоулучшитель и средство для витализации воды
DK1417324T3 (da) Fremgangsmåde til fremstilling af 2-keto-L-gulonsyre
ATE233728T1 (de) Verfahren zur reinigung von kreatin
BR0111412A (pt) Processos para recuperar um ácido orgânico ou um sal de metal do mesmo de uma fase alcoólica
KR960004365A (ko) 5'-리보뉴클레오티드칼슘의 제조방법
RO113970B1 (ro) Procedeu de obţinere a iodurii de potasiu de calitate reactiv
ES2194745T3 (es) Procedimiento para la obtencion de 4,6-dicloropirimidi-na.
WO2007016209A3 (en) Pure 1,2-benzisoxazole-3-methane-sulfonic acid sodium salt and purification process